Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Legend Biotech Announces Appointment of Chief Medical Officer
Legend Biotech, a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening […]
Treventis Partners its Preclinical Program in Alzheimer's Disease with Takeda
Treventis Corporation, a privately held biotechnology company, announced today that it has entered an option, […]
Discovery Life Sciences Acquires ReachBio Research Labs
Discovery Life Sciences, the Biospecimen and Biomarker Specialists™, has acquired Seattle-based ReachBio Research Labs (ReachBio®), […]
DiaMedica Therapeutics Appoints David Wambeke as Chief Business Officer
DiaMedica Therapeutics, a clinical-stage biopharmaceutical company focused on developing a novel treatment for acute ischemic […]
Foundation Medicine and Bristol Myers Squibb Expand Partnership to Focus on Companion Diagnostic Development
Foundation Medicine, a pioneer in molecular profiling for cancer announced today, an expanded collaboration with […]
Cumulus Neuroscience Expands Development Support of Novel Precision CNS Therapeutics
Cumulus Neuroscience, a global digital health company focused on advancing neuroscience clinical trials and patient […]
Peptilogics to Present Data in Patients Undergoing DAIR for the Treatment of Periprosthetic Joint Infection at ECCMID 2023
Peptilogics, a clinical-stage biotechnology company, has completed the enrollment of a Phase 1b trial for […]
SentiAR Announces Close of $8.5 million Series B Financing
SentiAR, a St. Louis, Missouri-based pioneer in using Augmented Reality (AR) visualization technology for medical procedures, […]
Glooko Announces Partnership with Insulin Dosing Algorithm Company Hedia
Glooko announced today a new Global partnership with Hedia, integrating its technology into Glooko’s diabetes […]
HuidaGene Appoints New Members to the Scientific Advisory Board
HuidaGene Therapeutics (辉大基因; HuidaGene), a global clinical-stage biotechnology company focused on developing genomic medicine, has […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more